Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-16LGND144STEPHEN L. SABBA plan to sell securities of LIGAND PHARMACEUTICALS INCORPORATED under Form 144MEDIUM
STEPHEN L. SABBA filed Form 144 to notify SEC of plan to sell 2145 units of LIGAND PHARMACEUTICALS INCORPORATED securities around 2026-06-16, with aggregate market value of $544,830.00. The total outstanding units is 20041061.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transacti...
Mid CapBiotechnology
2026-06-16BLTE144Dr. Hendrick P. Scholl plan to sell securities of Belite Bio, Inc. under Form 144MEDIUM
Dr. Hendrick P. Scholl filed Form 144 to notify SEC of plan to sell 10000 units of Belite Bio, Inc. securities around 2026-06-16, with aggregate market value of $1,442,400.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Mid CapBiotechnology